Please login to the form below

Not currently logged in

The inVentiv Health Communications Award for Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Back to Results

Highly Commended

HCV Action: A unique partnership of hepatitis C healthcare professionals

by The Hepatitis C Trust

Summary of work

HCV Action is a unique partnership of hepatitis C healthcare professionals, the pharmaceutical industry and patients. It is a network that promotes and shares useful materials, news, events and good practice between hepatitis C health professionals across the country through monthly e-updates and a website,

HCV Action is led by a steering committee, chaired by Dr Stephen Ryder, with GP, nurse, consultant, Public Health England, patient and industry representation. The group is co-funded by Janssen, Roche and MSD, who all sit on the steering committee. The Hepatitis C Trust has provided secretariat support to the group since September 2010. All decisions are made by consensus towards our shared aim: to ensure that hepatitis C is effectively addressed across the UK through prevention, early diagnosis, successful treatment and care.

Between July 2011 and December 2012, HCV Action’s membership increased from 200 to over 1,000 healthcare professionals. In response to the healthcare reforms, we developed and published a pioneering Hepatitis C Adult Services Commissioning Toolkit (October 2012), Public Health England has asked us to present the Toolkit at their first Annual Conference in 2013 and four national charities have followed the formula to develop similar commissioning toolkits.

Judges comments

Through good collaboration these HCPs became the voice of the hepatitis C professional community and there was a national focus which was great. They engaged Public Health England and produced a toolkit which can be used by commissioners. We liked the simple three-pronged tactic, impressive support materials and good results.


Maintaining Adherence Programme - by Janssen with support from Havas Lynx


Improving Anaphylaxis Treatment – A North West Initiative - by ALK-Abelló Ltd

The London Joint Working Group on Substance Misuse and Hepatitis C (LJWG) - by LJWG with support from Dovetail Strategies funded by: Janssen, MSD, Reckitt Benckiser Pharmaceuticals, and Roche Products

Addressing the Base of the Pyramid - by Novo Nordisk A/S with support from Lagos State Government, General Hospital Ikorodu and Sunny Kuku Foundation

Helping foster an unlikely partnership between Endocrinologists and Nephrologists: the European Hyponatraemia Network (EHN) - by Otsuka Pharmaceutical Europe Ltd. with support from Apothecom, a Huntsworth Health Company

Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021